{
    "Question": "MetaImmuneTech Inc CES 2024 product highlight and specification",
    "Summary": "MetaImmuneTech Inc\n\nProduct: CELLYTICS_NK Immunity Diagnosis Solution\n\n- Measures NK (Natural Killer) cell activity in patients quickly and cost-efficiently\n- Designed to provide insights into NK cell activity for patients receiving cancer therapy based on their immune system\n- Based on lens-free shadow imaging technology, allowing the sample to be processed within two hours\n- Uses machine learning to analyze captured images and produce an automated analysis\n- No experts or technicians required for operation, suitable for point-of-care use\n- Business model includes device and consumable sales, analytical services, software customizations/upgrades, research partnerships, and intellectual property licensing\n- Aims to demonstrate a clear productivity advantage and social impact on medical outcomes\n",
    "Summary_cn": "MetaImmuneTech Inc\n\n产品：CELLYTICS_NK 免疫诊断解决方案\n\n- 快速、经济高效地测量患者的自然杀伤细胞（NK细胞）活性\n- 旨在为接受基于免疫系统的癌症疗法的患者提供关于NK细胞活性的洞察\n- 基于无透镜阴影成像技术，样本可在两小时内处理\n- 使用机器学习分析捕获的图像并生成自动分析结果\n- 操作无需专家或技术人员，适用于现场使用\n- 商业模式包括设备和耗材销售、分析服务、软件定制/升级、研究合作伙伴关系和知识产权许可\n- 旨在展示明显的生产效益优势，并对医疗结果产生社会影响。"
}